Yes, DNA-PKcs has potential as a biomarker for cancer diagnosis and prognosis. Elevated levels of DNA-PKcs can indicate an ongoing response to DNA damage, which may be prevalent in cancer cells. Its expression levels could be used to predict the aggressiveness of the tumor and the likely response to therapies that induce DNA damage.
